Stockreport

Bristol Myers (BMY) Gains EU Approval for Breyanzi in Mantle Cell Lymphoma—What Does This Mean? [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Earlier this week, Bristol Myers Squibb announced that the European Commission approved its CAR-T cell therapy Breyanzi for adults with relapsed or refractory mantle cel [Read more]